Menu
DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence
Podcast image
Is Chiral Switching Still Relevant in Today’s Pricing Control Scenario?
0 secs; July 26, 2024
How to Develop a Competitive Edge in Generic Drug Development
0 secs; July 25, 2024
How to Find Key Starting Materials (KSMs) for Pharmaceutical APIs
0 secs; July 25, 2024
How to Navigate the Generic Drug Market Post-COVID
0 secs; July 25, 2024
The Regulatory Maze: How Generic Drugs Navigate FDA Approval
0 secs; July 24, 2024
Drafting Detailed Drug Patent Claims: The Art and Science of Pharmaceutical IP Protection
0 secs; July 24, 2024
Biologic Product Hopping: Innovation or Market Manipulation?
0 secs; July 24, 2024
The Chiral Switch: A Pharmaceutical Tactic to Prolong Exclusivity
0 secs; July 23, 2024
Cracking the Biosimilar Code: A Deep Dive into Effective IP Strategies
0 secs; July 22, 2024
Understanding the Patent Trial and Appeal Board (PTAB) – A Comprehensive Overview
0 secs; July 21, 2024
From Chaos to Clarity: Mastering Your CDMO Transition Like a Pro
0 secs; July 18, 2024
Winning Drug Patent Disputes: Proven Strategies for Pharmaceutical Companies
0 secs; July 17, 2024
Navigating Patent Opposition in Drug Patenting: A Comprehensive Guide
0 secs; July 16, 2024
The Complexity Advantage: Why Advanced Delivery Methods Deter Generic Competition
0 secs; July 15, 2024
Rx for Change: How Nonprofit Pharma is Reshaping the Industry
0 secs; July 15, 2024
CDMO Value Proposition: Why It Matters
0 secs; July 11, 2024
Biosimilar Patent Dance: Leveraging PTAB Challenges for Strategic Advantage
0 secs; July 11, 2024
Viagra’s Resilience in the Face of Generic Competition: A Pharmaceutical Market Analysis
0 secs; July 10, 2024
The impact of biosimilars on biologic drug distribution models
0 secs; July 09, 2024
Unified Patent Court Reshapes European Patent Landscape
0 secs; July 09, 2024
How to find low-competition generic drug opportunities
0 secs; July 09, 2024
Patenting Drugs Developed with Artificial Intelligence: Navigating the Legal Landscape
0 secs; July 08, 2024
China Leads in AI-Driven Drug Discovery Patents, Signaling Pharmaceutical Innovation Boom
0 secs; July 06, 2024
The Power of Patience: Delaying Patents to Enhance Pharma Market Exclusivity
0 secs; July 02, 2024
How can pharmaceutical marketing evolve with generic entry? The example of Lipitor
0 secs; July 01, 2024
DrugPatentWatch Week in Review
0 secs; June 29, 2024
Best Practices for Drug Patent Portfolio Management
0 secs; June 27, 2024
What is the market forecast for Ozempic?
0 secs; June 26, 2024
The Double-Edged Sword: Opportunities and Challenges in China’s Patent Litigation System
0 secs; June 26, 2024
Introducing DrugChatter: Revolutionizing Information Access
0 secs; June 25, 2024
USPTO Study Reveals Trends and Insights into Drug Patent and Exclusivity Trends in the Pharmaceutical Industry
0 secs; June 25, 2024
Leveraging 505(b)(2) to Innovate Beyond Existing Drug Patents
0 secs; June 24, 2024
The Intricate Journey of Drug Patents: From Filing to Expiry
0 secs; June 20, 2024
Uncovering Lucrative Low-Competition Generic Drug Opportunities
0 secs; June 19, 2024
Maximizing ROI with Branded Generics: A Comprehensive Guide
0 secs; June 18, 2024
A Practical Guide to FtO Analysis for Drug Repurposing Ventures
0 secs; June 17, 2024
Divisional Patent Minefields: Navigating Big Pharma’s Patent Extension Strategies
0 secs; June 17, 2024
Innovative Approaches to Extend the Life of Drug Patents
0 secs; June 17, 2024
How long does a patent last for drugs?
0 secs; June 12, 2024
Crucial Insights on Patent Litigation Strategies in Pharma Industry
0 secs; June 10, 2024
Underutilized Opportunities: Exploring Patent Term Extensions for Medical Devices
0 secs; June 06, 2024
Innovative Strategies in Drug Repurposing
0 secs; April 23, 2024
AI-Driven Drug Discovery: Transforming the Landscape of Pharmaceutical Research
0 secs; April 16, 2024
Innovative Financing Models for Repurposing Generic Drugs
0 secs; April 11, 2024
Biosimilar Competition Does Not Reduce Patient Out-of-Pocket Costs for Biologic Drugs
0 secs; March 31, 2024
Unleashing Innovation: The Case for Permissionless R&D in Pharma
0 secs; March 22, 2024
LACTOSE-Free Medicines: Which Drugs Contain LACTOSE?
0 secs; March 07, 2024
GELATIN-Free Medicines: Which Drugs Contain GELATIN?
0 secs; March 06, 2024
Cost-Cut Without Compromise: Navigating Excipient Switching in Pharma
0 secs; February 26, 2024
Drug Excipient Business Development Reports now Available on Amazon
0 secs; February 15, 2024
Revolutionizing Patent Landscaping: A Human-Supervised AI Approach to Identify Tech Clusters
0 secs; January 30, 2024
Legislative Proposals to Tackle Improper Pharmaceutical Patents in the Orange Book
0 secs; January 22, 2024
An AI Approach to Generate Novel Pharmaceuticals using Patent Data
0 secs; January 16, 2024
NPR on how low Drug Prices can Cause Shortages
0 secs; January 09, 2024
Unveiling the Secrets of Patent Litigation and Settlements in Pharmaceuticals
0 secs; January 08, 2024
Decoding Pfizer’s Portfolio: A New Model for Precision in Pharma Investments
0 secs; December 10, 2023
Navigating Legal Waters: Study Delves into Inequitable Conduct in Drug Patent Cases
0 secs; November 17, 2023
AI-Driven Strategies: Pharma’s Answer to Patent Expirations
0 secs; November 12, 2023
Maximizing Intellectual Property Value in the Biomedical Sector: A Case Study on Rucaparib Patents
0 secs; November 06, 2023
Advancements in In Silico ADMET Modeling: A 20-Year Journey of Machine Learning in Drug Discovery at Bayer Pharma
0 secs; October 30, 2023
List of research papers citing DrugPatentWatch
0 secs; October 25, 2023
Influencers of Generic Drug Utilization
0 secs; October 16, 2023
Reviving an R&D Pipeline
0 secs; October 09, 2023
Factors that May Predict the Likelihood of Generic Drug Marketing Applications
0 secs; October 02, 2023
Measuring Patent Value Indicators
0 secs; September 25, 2023
Maximizing Drug Patents’ Value: Strategies for Biomedical Companies
0 secs; September 18, 2023
From Expert AI to Snackable AI: A New Era in Pharma, as Seen by Sanofi’s CEO
0 secs; September 12, 2023
Understanding Patent Term Extensions: An Overview
0 secs; September 12, 2023
Pharmacists Can Play Key Role in Drug Repurposing
0 secs; September 05, 2023
Key Factors for Choosing the Right CDMO
0 secs; August 28, 2023
Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry
0 secs; August 21, 2023
Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review
0 secs; August 15, 2023
Drug Patent Reports now available on Amazon
0 secs; August 14, 2023
Artificial Intelligence and Machine Learning in Drug Discovery and Development
0 secs; August 10, 2023
Prevalence and timing of authorized generics in the US market
0 secs; August 08, 2023
Insights into Shifting Dynamics: Orange Book and Biologic PTAB Trends
0 secs; August 07, 2023
The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation
0 secs; August 05, 2023
Understanding the Impact of Authorized Generics on Drug Pricing: The Entacapone Case Study
0 secs; August 02, 2023
Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations
0 secs; July 28, 2023
DrugPatentWatch reveals NIH funding for patents
0 secs; July 27, 2023
Filing Strategies for Maximizing Pharma Patents
0 secs; July 25, 2023
17th Edition Project Portfolio and Resource Management Excellence for Pharma
0 secs; June 08, 2023
DrugChatter Featured Questions
0 secs; June 08, 2023
DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights
0 secs; May 22, 2023
NPR and DrugPatentWatch – Can drug injector pens be swapped?
0 secs; May 16, 2023
Utilizing 505(b)(2) Regulatory Pathway for New Drug Applications: An Overview on the Advanced Formulation Approach and Challenges
0 secs; April 19, 2023
Social Return on Investment
0 secs; September 06, 2022
CDCDB: A large and continuously updated drug combination database
0 secs; June 07, 2022
DrugPatentWatch named “Best of the Web” by Genetic Engineering News
0 secs; May 02, 2022
Join DrugPatentWatch at the 15th Pharma Resource Planning and Portfolio Optimization Conference
0 secs; April 14, 2022
The value of method of use patent claims in protecting your therapeutic assets
0 secs; April 05, 2022
DrugPatentWatch Week in Review
0 secs; March 22, 2022
2 Strategies to Grow Your Excipient Business by Tracking Drug Patents
0 secs; March 22, 2022
Free Online Course on Drug Patents, Generic and Branded Drugs
0 secs; March 10, 2022
DrugPatentWatch Ranked Best Biopharmaceuticals Commercial Business Intelligence Platform
0 secs; October 20, 2021
DrugPatentWatch Custom Market Surveillance
0 secs; October 20, 2021
Updating the DrugPatentWatch Biologics Module
0 secs; October 20, 2021
Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades
0 secs; October 20, 2021
Development of Generic Drug Products by Pharmaceutical Industries Considering Regulatory Aspects: A Review
0 secs; October 12, 2021
Generic Portfolio Management, Partnering with Brands, and Staying Competitive
0 secs; October 04, 2021
Click here to see more
Useful pages

Apply to teach

Reviews

Help & FAQs

Blog

Spanish Podcast

French Podcast

Italian Podcast

About Us

Contact Us

Terms & Privacy

Find a tutor

Arabic tutors

Chinese tutors

Dutch tutors

English tutors

French tutors

German tutors

Greek tutors

Italian tutors

Japanese tutors

Korean tutors

Portuguese tutors

Romanian tutors

Russian tutors

Spanish tutors

Swedish tutors

Thai tutors

More languages soon!

Languages

Learn Arabic

Learn Chinese

Learn Dutch

Learn English

Learn French

Learn German

Learn Greek

Learn Italian

Learn Japanese

Learn Korean

Learn Portuguese

Learn Romanian

Learn Russian

Learn Spanish

Learn Swedish

Learn Thai

© 2026 LanguaTalk, All Rights Reserved